Multiple myeloma: the bone-marrow cancer explained plainly
Last updated September 3, 2026.
Multiple myeloma is the blood cancer of the plasma cells (the antibody-making cells in the bone marrow): the rogue cells crowding the marrow and producing the useless antibody (the paraprotein), causing the bone damage (the pain, the fractures), the anemia, the infections, the kidney problems, and the high calcium. It is mostly the over-65s, it is found through the blood-and-urine tests after the symptoms like the persistent back pain or the anemia, and while it is not usually curable, the modern treatments (the combinations, the transplant, the newer antibodies) control it for the years: the survival has doubled over the past two decades.
What are the symptoms?
The CRAB features the textbooks use: the Calcium high (the thirst, the confusion, the constipation), the Renal (the kidneys failing), the Anemia (the fatigue, the breathlessness), the Bone (the persistent pain: the back, the ribs: the fractures-from-minor-knocks: the collapsed vertebrae), plus the recurrent infections (the immunity suppressed) and the unexplained weight loss. The persistent back pain with the anemia in the over-60s is the classic trigger for the testing.
How is it diagnosed?
The blood-and-urine tests (the paraprotein, the free light chains), the bone-marrow biopsy (the plasma-cell percentage), and the imaging (the whole-body low-dose CT-or-MRI now: the bone lesions mapped), with the staging combining them. The related early stages (the MGUS, the smoldering kind: the monitored-not-treated precursors) get the watching, not the treatment.
How is it treated?
- The initial combinations: the triplets (the proteasome-inhibitor-plus-immunomodulator-plus-steroid kind), the response rates high.
- The stem-cell transplant for the fit: the high-dose chemo with the own-cells rescue (the deepening the response: the years of the remission).
- The newer wave: the monoclonal antibodies (the daratumumab-kind), the CAR-T cells, and the bispecific antibodies for the relapsed kind (the options deep: the field moving fast).
- The support care as the equal half: the bone-protecting infusions (the bisphosphonates), the infection prevention (the vaccines, the prompt antibiotics), the kidney protection, the pain-and-fracture management, and the blood-transfusions when needed.
When is it urgent?
The same-day for: the new back pain with the leg weakness-or-numbness or the bladder-bowel changes (the cord compression: the emergency), the confusion with the dehydration (the high calcium), the fevers, or the severe breathlessness. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
Is multiple myeloma curable?
The honest answer: not usually, in the strict cure sense (the disease typically returns at some point), but the control era has changed what that means: the treatments induce the deep remissions (the years-long for many), the relapses get the next-line treatments (the drug cupboard now deep: the antibodies, the CAR-T, the transplant), and the many patients live the decade-and-more with the good-quality life between the treatment periods. The framing the teams use: the chronic-condition management, with the cure research advancing.
Why did my bones break?
The myeloma's signature damage: the rogue plasma cells switch on the bone-eating cells (the osteoclasts: the bone dissolved faster than built: the lytic lesions), leaving the vertebrae and the ribs prone to the crush-and-break from the ordinary loads. The bone-protection infusions (the bisphosphonates-or-denosumab: the bone-eating slowed) run alongside the cancer treatment, and the healed-stabilized spine often improves substantially once the disease is controlled.
What is the stem-cell transplant?
The own-cells kind (the autologous): the stem cells collected from your blood first, the high-dose chemotherapy then wiping the marrow (the myeloma with it), and the stored cells returned to rebuild it: the weeks of the recovery, the deeper-longer remission the payoff, and the fit-and-eligible assessed carefully (the 62 with the reasonable fitness is the typical candidate age). It is the standard intensification, not the experimental: the decades of the refinement behind it.
Why do I keep getting infections?
The double-hit: the myeloma crowds out the normal antibody-making cells (the useful antibodies falling) while the paraprotein is the useless kind, and the treatments suppress the immunity further. The practical defenses: the vaccinations current (the flu-COVID-pneumonia-shingles kind: the inactivated versions), the fever-is-the-emergency rule (the 38-C-or-100.4-F kind: the same-day, every time, especially on the treatment), and the prompt antibiotics culture. The infection, not the myeloma itself, is the commonest acute danger in the treatment era.
What does the paraprotein in my blood mean?
The fingerprint of the disease: the rogue plasma cells all pumping out the one identical antibody (the monoclonal, the paraprotein: useless as the immunity but perfect as the tracker), and its level becomes your personal graph (the falling with the treatment, the rising with the relapse: the monitoring watching it for the years). The kidney note: the paraprotein's fragments can clog the kidneys (the fluids kept up, the kidney tests routine), which is part of why the treatment urgency varies by the organ involvement.
How do I live between the treatment cycles?
The real-life layer: the fatigue managed by the pacing (the energy budgeted: the good days not overspent), the infections avoided (the crowds-in-the-season caution, the food-hygiene basics), the bone-safe movement (the walking-and-gentle-kind: the lifting-maximal and the high-impact avoided while the bones are fragile), the pain reported not endured (the uncontrolled pain is the undertreated pain), and the mental health taken as seriously as the bloods (the support groups and the myeloma-specialist nurses: the useful kind). The normal-life ambitions stay on the table: the treatment is built around them.